Gentiva Reports Fourth Quarter and Fiscal 20...(010 9939 Reversal of tax audit...)

Date:2/18/2009

010 9,939 Reversal of tax audit reserves - (450) Equity-based compensation expense 5,757 6,812 Windfall tax benefits associated with equity- based compensation (2,227) (856) Gain on sale of business, net (107,933) - Equity in net loss of affiliate 35 - Deferred income taxes 14,127 20,923 Changes in assets and liabilities, net of effects from acquisitions and dispositions: Accounts receivable (25,555) (36,423) Prepaid expenses and other current assets (2,118) (3,531) Current liabilities (750) 12,606 Other, net 1,107 (254) ----- ---- Net cash provided by operating activities 70,700 62,671 ------ ------ INVESTING ACTIVITIES: Purchase of fixed assets (24,004) (24,064) Proceeds from sale of business, net of cash transferred 83,160 - Acquisition of businesses, net of cash acquired (60,736) (3,820) Purchases of short-term investments available- for-sale (28,000) (96,850) Maturities of short-term investments available- for-sale 46,250 89,925 Withdrawal from restricted cash 22,014 - ------ ------ Net cash provided by (used in) investing activities 38,684 (34,809)
'/>"/>

SOURCE Gentiva Health Services, Inc. Copyright©2009 PR Newswire. All rights reserved

1 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Related biology technology :

1. Gentiva Reports Strong Second Quarter led by Home Health Segment
2. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results